Literature DB >> 20396773

Molecular genetic and immunophenotypical analysis of Pax6 transcription factor and neural differentiation markers in human fetal neocortex and retina in vivo and in vitro.

B I Verdiev1, R A Poltavtseva, O V Podgornyi, M V Marei, R D Zinovyeva, G T Sukhikh, M A Aleksandrova.   

Abstract

Neurotransplantation of various cells, including heterotransplantation of fetal cerebral stem/progenitor cells into the eye is used in experimental studies of central nervous tissue repair during neurodegeneration. For evaluation of this approach, human fetal (weeks 9-20) stem/progenitor cells of the neocortex and retina were studied in vivo and in vitro by quantitative PCR and immunohistochemical staining. Native tissues and cultures were characterized by expression of Pax6 transcription factor (critical for the development of the retina and neocortex) and differentiation markers (nestin, betaIII-tubulin, glial fibrillary acidic protein, recoverin, NeuN, neurofilaments, Ki-67). The expression of Pax6 gene in the retina during active neurogenesis was stable and much higher than in the neocortex. In primary cultures, the pattern of Pax6 gene expression is retained and repeats that in native tissues. Immunohistochemical analysis revealed similarity of nestin and betaIII-tubulin expression in the neocortex and retina during the early (9-10 weeks) and later (20 weeks) periods and differences in cell phenotypes and their distribution. Culture studies showed that neocortical and retinal stem/progenitor cells are determined and exhibit specific differentiation characteristic of the corresponding native tissues. It can be hypothesized that heterotransplantation of the cerebral progenitor cells into the retina of experimental animals can lead to realization of their neurotrophic effect, but not to their functional integration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20396773     DOI: 10.1007/s10517-010-0797-3

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  5 in total

1.  Versatile activity and morphological effects of zinc oxide submicron particles as anticancer agents.

Authors:  Junnan Geng; Gregory Jensen; Kyle Jackson; Jefferson Pontsler; Venkatakrishnan Rengarajan; Yan Sun; David Britt; Yu Huang
Journal:  Nanomedicine (Lond)       Date:  2022-03-30       Impact factor: 6.096

2.  Pharmacotherapy alleviates pathological changes in human direct reprogrammed neuronal cell model of myotonic dystrophy type 1.

Authors:  Mougina K Eltahir; Masayuki Nakamori; Satoshi Hattori; Takashi Kimura; Hideki Mochizuki; Seiichi Nagano
Journal:  PLoS One       Date:  2022-07-01       Impact factor: 3.752

3.  NeuN As a Neuronal Nuclear Antigen and Neuron Differentiation Marker.

Authors:  V V Gusel'nikova; D E Korzhevskiy
Journal:  Acta Naturae       Date:  2015 Apr-Jun       Impact factor: 1.845

4.  Verification of the Cross Immunoreactivity of A60, a Mouse Monoclonal Antibody against Neuronal Nuclear Protein.

Authors:  Shanping Mao; Guoxiang Xiong; Lei Zhang; Huimin Dong; Baohui Liu; Noam A Cohen; Akiva S Cohen
Journal:  Front Neuroanat       Date:  2016-05-13       Impact factor: 3.856

5.  Comparison of Different Tissue Clearing Methods for Three-Dimensional Reconstruction of Human Brain Cellular Anatomy Using Advanced Imaging Techniques.

Authors:  Marina Scardigli; Luca Pesce; Niamh Brady; Giacomo Mazzamuto; Vladislav Gavryusev; Ludovico Silvestri; Patrick R Hof; Christophe Destrieux; Irene Costantini; Francesco S Pavone
Journal:  Front Neuroanat       Date:  2021-11-11       Impact factor: 3.856

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.